Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effectiveness of Assertive Continuing Care for Youth

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
Chestnut Health Systems
ClinicalTrials.gov Identifier:
NCT01085188
First received: March 10, 2010
Last updated: NA
Last verified: March 2010
History: No changes posted
  Purpose

Following discharge from residential treatment 324 adolescents are randomly assigned to Assertive Continuing Care with and without motivational incentives in a 2 x 2 factorial design. Clinical outcomes are assessed at 3, 6, 9, and 12 months post discharge.


Condition Intervention Phase
Substance Use Disorders
Behavioral: ACC
Behavioral: CM
Behavioral: UCC
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Primary Purpose: Treatment

Further study details as provided by Chestnut Health Systems:

Enrollment: 342
Study Start Date: January 2003
Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Assertive Continuing Care (ACC)
Behavioral intervention comprised of the community reinforcement approach plus case management delivered in home and other community settings to youth and their caregivers.
Behavioral: ACC
Weekly community based behavioral counseling and case management
Behavioral: UCC
recommendation made by discharge counselor upon leaving residential treatment to attend nearest outpatient clinic.
Experimental: Contingency Management (CM)
Using a prize drawing system (no, low, medium and large value prizes) with adolescents could earn escalating prize drawing opportunities by completing verifiable pro-social activities and providing negative urine test and breath alcohol test results.
Behavioral: CM
Weekly community based prize drawing opportunities contingent upon completed verifiable pro-social activities and clean urine and breath alcohol test results
Behavioral: UCC
recommendation made by discharge counselor upon leaving residential treatment to attend nearest outpatient clinic.
Experimental: ACC + CM
This arm is the combination of arms 1 and 2.
Behavioral: ACC
Weekly community based behavioral counseling and case management
Behavioral: CM
Weekly community based prize drawing opportunities contingent upon completed verifiable pro-social activities and clean urine and breath alcohol test results
Behavioral: UCC
recommendation made by discharge counselor upon leaving residential treatment to attend nearest outpatient clinic.
Active Comparator: Usual Continuing Care (UCC)
UCC consists of a discharge recommendation to seek aftercare services at nearest treatment provider to where the patient lived. This service primarily consisted of outpatient group counseling.
Behavioral: UCC
recommendation made by discharge counselor upon leaving residential treatment to attend nearest outpatient clinic.

  Eligibility

Ages Eligible for Study:   12 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Met DSM-IV diagnostic criteria for abuse or dependence on alcohol or another drug in the past year
  • Been between the ages of 12 and 18 at the time of residential admission; and (c) resided in one of ten Illinois counties targeted for the intervention

Exclusion Criteria:

  • left residential treatment prior to the seventh day
  • did not return to a target county at discharge
  • showed evidence of cognitive impairment that interfered with understanding of study instruments, procedures, or the informed consent process
  • were deemed dangerous to themselves or others during treatment
  • were a ward of child protective services and inaccessible for the intervention
  • met DSM-IV criteria for pathological gambling
  • were discharged to the state department of corrections
  • were already participating in a treatment study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Mark D. Godley, Ph.D./Director of Research and Development, Chestnut Health Systems
ClinicalTrials.gov Identifier: NCT01085188     History of Changes
Other Study ID Numbers: 1018-1201
Study First Received: March 10, 2010
Last Updated: March 10, 2010
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on November 25, 2014